Evidence map›Paper›PMID 36973671›Full record

ArticleBMC cardiovascular disorders2023

The characteristics of elevated blood pressure in abdominal obesity correspond to primary hypertension: a cross-sectional study.

Jyrki Taurio, Elina J Hautaniemi, Jenni K Koskela, Arttu Eräranta, Mari Hämäläinen, Antti Tikkakoski, Jarkko A Kettunen, Mika Kähönen, Onni Niemelä, Eeva Moilanen and 2 more

Registry-linked trialFull text read
In one paragraph

Article in BMC cardiovascular disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01742702 (Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01742702 unknown statusnot on this map

Non-Invasive HaemoDYNAMICs in Primary and Secondary Hypertension: the DYNAMIC-study

TypeobservationalSponsorTampere UniversityRan2006 to 2025Enrolled2,000ConditionsPrimary Hypertension, Secondary Hypertension, Aortic Stenosis, Renal InsufficiencyArmsNitroglycerin 0.25 mg (single dose, no longer given since January 2017), Salbutamol 400 µg (single dose, no longer given since January 2017), L-arginine (10 min infusion, no longer given since January 2017), Liquorice (2 weeks, glycyrrhizin 290-370 mg daily, no longer given since 2012), Small milk casein-derived polypeptides (12 weeks daily, recordings completed 2011)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jyrki TaurioDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Elina J HautaniemiFaculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Jenni K KoskelaDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Arttu ErärantaFaculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Mari HämäläinenThe Immunopharmacology Research group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.
Antti TikkakoskiFaculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Jarkko A KettunenFaculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Mika KähönenFaculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Onni NiemeläFaculty of Medicine and Health Technology, Tampere University, FI-33014, Tampere, Finland.
Eeva MoilanenThe Immunopharmacology Research group, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland.
Jukka MustonenDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Ilkka PörstiDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland. ilkka.porsti@tuni.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity-related hypertension and the associated metabolic abnormalities are considered as a distinct hypertensive phenotype. Here we examined how abdominal fat content, as judged by waist:height ratio, influenced blood pressure and hemodynamic profile in normotensive subjects and never-treated hypertensive patients.

methodsThe 541 participants (20-72 years) underwent physical examination and laboratory analyses and were divided into age and sex-adjusted quartiles of waist:height ratio. Supine hemodynamics were recorded using whole-body impedance cardiography, combined with analyses of radial tonometric pulse wave form and heart rate variability.

resultsMean waist:height ratios in the quartiles were 0.46, 0.51, 0.55 and 0.62. Radial and aortic blood pressure, systemic vascular resistance, pulse wave velocity, markers of glucose and lipid metabolism, leptin levels and C-reactive protein were higher in quartile 4 when compared with quartiles 1 and 2 (p < 0.05 for all). Cardiac index was lower in quartile 4 versus quartile 1, while no differences were seen in heart rate variability, augmentation index, plasma renin activity, and aldosterone concentration between the quartiles. Linear regression analyses showed independent associations of abdominal obesity with higher aortic systolic and diastolic blood pressure, systemic vascular resistance, and pulse wave velocity (p < 0.05 for waist:height ratio in all regression models).

conclusionHigher waist:height ratio was associated with elevated blood pressure, systemic vascular resistance, and arterial stiffness, but not with alterations in cardiac sympathovagal modulation or activation of the circulating renin-angiotensin-aldosterone system. Although obesity-related elevation of blood pressure has distinct phenotypic features, these results suggest that its main characteristics correspond those of primary hypertension.

trial registrationClinicalTrails.gov NCT01742702 (date of registration 5th December 2012).

Indexed as

HypertensionObesity, AbdominalBlood PressureCross-Sectional StudiesEssential HypertensionHemodynamicsHumansObesityPulse Wave AnalysisVascular StiffnessAbdominal obesityHemodynamicsHypertensionImpedance cardiographyPulse wave analysis

Identifiers

PMID36973671
PMCPMC10045516

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read28
identifiers read1
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.